New Chair brings extensive financial and life sciences experience with industry-leading companies SOUTH SAN FRANCISCO — Mission Bio, the pioneer in high-throughput single-cell DNA and multi-omics analysis, today announced it has appointed Stuart Essig, PhD, as Chair of its Board of Directors. Dr. Essig is currently a Managing Partner of Prettybrook Partners and Chairman of the […]

MENLO PARK, Calif. — Gamma Biosciences, a global life sciences company formed by KKR to serve the advanced therapy market with best-in-class bioprocessing solutions, today announced that Kieran P. Murphy will join its Board of Directors as Executive Chairman. With a long track record of building leading businesses in biopharma and life sciences, Mr. Murphy […]

BILLERICA, Mass. — Bruker Corporation (Nasdaq: BRKR) today announced that its Board of Directors has appointed Philip Ma, Ph.D. to serve on its board, effective as of April 1, 2022. Dr. Ma is Chief Executive Officer, founder, and a director of PrognomiQ, a privately held healthcare company that is developing next-generation, transformative multiomics products to enable […]

Experienced Product and Operations Leader to Accelerate Delivery of Ambitious Roadmap in Single Cell Genomics SAN DIEGO, Calif. and CAMBRIDGE, UK — CS Genetics, a privately held genomics-technology company, today announced the appointment of Jay Harger, PhD, as Senior Vice President of Operations. Jay will lead a variety of critical company operations including facilities, manufacturing […]

LONG ISLAND CITY, N.Y. — Opentrons Labworks, Inc., today announced the appointments of Eva Boratto as chief financial officer and member of the board of directors, and Veleka Peeples-Dyer as chief legal and compliance officer. The breadth of Boratto’s and Peeples-Dyer’s expertise and influence position the company to accelerate its strategic plans for growth and […]

Tokyo – Hitachi High-Tech Corporation today announced the change of Executive Officers as follows. Executive Officers (Effective April 1, 2022) The underlined parts are changes effective April 1, 2022. Title Name                             Responsibilities                     […]

SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN) announced today that Carissa Rollins will join the company as Chief Information Officer on March 14, 2022. Rollins brings over 30 years of business technology transformation and digital and consumerization strategy experience. Rollins will report to Chief Executive Officer, Francis deSouza. Most recently, Rollins was the Chief Information […]

London, UK – UK genomics company, RevoluGen Ltd. (RevoluGen or the Company), today announces that Nick McCooke, widely recognised leader in the next generation sequencing (NGS) field, has been appointed as Strategic Advisor. Nick was the founding CEO of pioneering NGS company Solexa, which he took from spin-out to its NASDAQ listing in 2005. Solexa was […]

EMERYVILLE, Calif. — Berkeley Lights, Inc. (Nasdaq: BLI) (“Berkeley Lights” or the “Company”) a leader in digital cell biology, today announced it has appointed Dr. Siddhartha Kadia as its new chief executive officer (CEO), effective immediately. Dr. Kadia succeeds Eric D. Hobbs, Ph.D., as part of the previously announced leadership transition. Dr. Kadia will remain […]

DNA sequencing veteran Kevin Corcoran joins as CEO SANTA CRUZ, Calif. — Nooma Bio, Inc., an innovator in the use of dual-nanopore technology to detect genome-wide structural and epigenetic variation, has announced a new leadership team including DNA sequencing veteran Kevin Corcoran as Chief Executive Officer. Mr. Corcoran has more than 30 years of experience […]